SEC Form 4 · accession 0001209191-15-023554
Flexion Therapeutics Inc · FLXN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Scott A Canute
Director
Period of report
Mar 4, 2015
Accepted (ET)
Mar 6, 2015 · 4:36 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001419600
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $25.38 | Mar 4, 2015 | A | 18,000 | A | — | Mar 3, 2025 | Common Stock | 18,000 | 18,000 | D |
Explanation of responses
- F1One-third of the shares subject to the option will vest on March 4, 2016 and the balance of the shares will vest in a series of 24 equal monthly installments thereafter.